John Hussman's BIIB Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 6,300 shares of Biogen Inc. (BIIB) worth $1.15 M, representing 0.25% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in BIIB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2013, adding 25,000 shares. Largest reduction occurred in Q4 2013, reducing 75,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Biogen (BIIB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Biogen (BIIB) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +6,300 | New Buy | 6,300 | $183.33 |
| Q4 2024 | -6,300 | Sold Out | 0 | $0.00 |
| Q2 2023 | +6,300 | New Buy | 6,300 | $284.85 |
| Q3 2022 | -21,700 | Sold Out | 0 | $0.00 |
| Q2 2022 | +3,500 | Add 19.23% | 21,700 | $203.92 |
| Q1 2022 | +5,200 | Add 40.00% | 18,200 | $210.60 |
| Q4 2021 | +5,250 | Add 67.74% | 13,000 | $239.92 |
| Q3 2021 | +4,650 | Add 150.00% | 7,750 | $282.97 |
| Q2 2021 | -9,200 | Reduce 74.80% | 3,100 | $346.13 |
| Q4 2020 | -5,600 | Reduce 31.28% | 12,300 | $244.88 |
| Q3 2020 | -50 | Reduce 0.28% | 17,900 | $283.69 |
| Q2 2020 | +5,025 | Add 38.88% | 17,950 | $267.58 |
| Q1 2020 | +2,925 | Add 29.25% | 12,925 | $316.36 |
| Q4 2019 | +2,500 | Add 33.33% | 10,000 | $296.70 |
| Q3 2019 | -2,500 | Reduce 25.00% | 7,500 | $232.80 |
| Q1 2019 | +2,500 | Add 33.33% | 10,000 | $236.40 |
| Q4 2018 | +7,500 | New Buy | 7,500 | $300.93 |
| Q3 2018 | -5,000 | Sold Out | 0 | $0.00 |
| Q2 2018 | -5,000 | Reduce 50.00% | 5,000 | $290.20 |
| Q1 2018 | +10,000 | New Buy | 10,000 | $273.80 |
| Q3 2017 | -10,000 | Sold Out | 0 | $0.00 |
| Q2 2017 | +9,750 | Add 3900.00% | 10,000 | $271.40 |
| Q1 2017 | -100 | Reduce 28.57% | 250 | $272.00 |
| Q4 2016 | +350 | New Buy | 350 | $282.86 |
| Q4 2013 | -75,000 | Sold Out | 0 | $0.00 |
| Q3 2013 | +25,000 | Add 50.00% | 75,000 | $240.76 |
| Q2 2013 | +50,000 | Add 0.00% | 50,000 | $215.20 |
John Hussman's Biogen Investment FAQs
John Hussman first purchased Biogen Inc. (BIIB) in Q2 2013, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Biogen Inc. (BIIB) for 34 quarters since Q2 2013.
John Hussman's largest addition to Biogen Inc. (BIIB) was in Q2 2013, adding 50,000 shares worth $10.76 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 6,300 shares of Biogen Inc. (BIIB), valued at approximately $1.15 M.
As of the Q1 2026 filing, Biogen Inc. (BIIB) represents approximately 0.25% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Biogen Inc. (BIIB) was 75,000 shares, as reported at the end of Q3 2013.